Effect of hormone replacement therapy on lipids and left ventricular function in postmenopausal smokers

Climacteric

Volumn 7, Issue 4, 2004, Pages 366-374

  Beljic, T ^a   Babic, D T ^b   Babic, D ^b   Knezevic, N ^c   Drezgic, M ^c  

^a ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

^b Clinical Hospital Centre 'Be anijska kosa'   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Heart function; Hormone replacement therapy; Lipids; Smoking

Indexed keywords

CHOLESTEROL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROFEM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MITRAL VALVE; POSTMENOPAUSE; PRIORITY JOURNAL; SYSTOLE;

EID: 10944223543     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130400001778     Document Type: Article

References (34)

1. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83-90
2. Pines A, Fisman EZ, Drory Y, et al. Menopause-induced changes in Doppler-derived parameters of aortic flow in healthy women. Am J Cardiol 1992;69:1104-6
3. Pines A, Fisman EZ, Levo Y, et al. Menopause-induced changes in left ventricular wall thickness. Am J Cardiol 1992;72:240-1
4. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989;298:784-8
5. US Department of Health and Human Services. The Health Benefits of Smoking Cessation. A Report of the Surgeon General. USDHHS, Centers for Disease Control: Office of Smoking and Health. DHHS Publication (CDC) 1990;90-8416
6. Cassidenti DL, Vijod AG, Vijod MA, et al. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1990;163:1953-60
7. Barbieri RL, McShane RM, Ryan KJ. Constituents of cigarette smoke inhibit human granulose cell aromatase. Fertil Steril 1986;46:232-6
8. Haarbo J, Christiansen C. Treatment-induces cyclic variations in serum lipids, lipoproteins and apolipoproteins after 2 years of combined hormone replacement therapy: exaggerated cyclic variations in smokers. Obstet Gynecol 1992;80:639-44
9. Jensen J, Christiansen C, Rebro P. Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985;313:973-5
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density cholesterol in plasma, without use of the preparation ultracentrifugation. Clin Chem 1972;18:499-502
11. Rich-Edwards JW, Manson JE, Hennekens CH, et al. The primary prevention of coronary heart disease in women. N Engl J Med 1995;332:1758-66
12. Hardy R, Kuh D, Wadsworth M. Smoking, body mass index, socioeconomic status and the menopausal transition in a British national cohort. Int J Epidemiol 2000;29:845-51
13. Cooper GS, Sandler DP, Bohling M. Active and passive smoking and the occurrence of natural menopause. Epidemiology 1999;10:771-3
14. Crook D, Cust MP, Gangar KF, et al. Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 1992;166:950-5
15. Haarbo J, Hassager C, Schlemmer A, Christiansen C. The influence of smoking, body fat distribution and alcohol consumption on serum lipids, lipoproteins and apolipoproteins in early postmenopausal women. Atherosclerosis 1990;84:239-44
16. Tikkanen MJ. Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects. Am J Obstet Gynecol 1990;163:296-304
17. Scott RT, Ross B, Anderson C, et al. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991;77:758-64
18. Geisler J, Omsjo IH, Helle SI, Ekse D, Silsand T, Lonning PE. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration. J Endocrinol 1999;162:265-70
19. Mueck AO, Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Arzeimittelforschung 2003;53:1-11
20. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiological findings. Am Heart J 1986;111:932-40
21. Stewart MJ, Jyothinagaram S, McGinley IM, Padfield PL. Cardiovascular effects of cigarette smoking: ambulatory blood pressure and BP variability. Hum Hypertens 1994;8:19-22
22. Angerer P, Kothny W, Stork S, von Schacky C. Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial. J Am Coll Cardiol 2000;36:1789-96
23. Teede MJ, Liang YL, Shiel LM, McNeil JJ, McGrath P. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function. J Am Coll Cardiol 1999;34:131-7
24. Girdler SS, Hinderliter AL, West SG, et al. Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement. Am J Cardiol 2000;86:590-2
25. Prelevic GM, Beljic T. The effect of oestrogen and progestogen replacement on systolic flow velocity in healthy postmenopausal women. Maturitas 1994;20:37-44
26. Harrison MR, Clifton GD, Sublett KL, DeMaria AL. Effect of heart rate on Doppler indexes of systolic function in humans. J Am Coll Cardiol 1989;14:929-35
27. Lin AL, Shain SA. Estrogen-mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis 1985;5:668-77
28. Klangkalya B, Chan A. The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Sci 1988;42:2307-14
29. Majahalme S, Turjanmaa V, Weder A. Blood pressure levels variability, smoking, and left ventricular function in normotension and borderline and mild hypertension. Am J Hypertension 1996;9:1110-18
30. Voutilainen S, Hippelainen M, Hulkko S, et al. Left ventricular diastolic function by Doppler echocardiography in relation to hormone replacement therapy in healthy postmenopausal women. Am J Cardiol 1993;71:614-17
31. Alam M, Samad BA, Wardell J, Andersson E, Hoglund C, Nordlander R. Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging. J Am Soc Echocardiogr 2002; 15:1232-7
32. Kyrikades ZS, Kremastinos DT, Rentoukas E. Acute effects of cigarette smoking on left ventricular diastolic function. Eur Heart J 1992;13:7
33. Beljic T, Babic D, Marinkovic J, et al. The effects of hormone replacement therapy on diastolic left ventricular function in hypertensive and normotensive postmenopausal women. Maturitas 1998;29:229-33
34. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33